You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE Test

Cardiovascular Symptoms and COVID-19 in Pregnancy Requires a Team Approach

  1. You are a member of the healthcare team for a 27-year-old pregnant woman with COVID-19. According to the American College of Cardiology (ACC) review by Briller and colleagues from the Cardiovascular Disease (CVD) in Women Committee, which of the following statements about cardiovascular (CV) complications in women with pregnancy-associated COVID-19 is correct?
    Mechanisms for adverse COVID-19 outcomes in pregnancy may include immune system changes, clotting, older age, comorbidities, and racial/social disparities
    CV complications of COVID-19 in pregnancy are limited to macrovascular thrombotic complications
    Risk for myocardial injury in pregnancy is solely determined by severity of COVID-19
    Only cardiologists should manage cardiac complications of COVID-19 during pregnancy
  2. According to the ACC review by Briller and colleagues from the CVD in Women Committee, which of the following statements about approaches to diagnosis of CV complications in women with pregnancy-associated COVID-19 is correct?
    Pregnancy complications such as spontaneous coronary dissection (SCAD) and preeclampsia are easily differentiated from COVID-19 complications
    Clinicians should consider checking cardiac biomarkers in pregnant women with moderate or severe COVID-19
    Electrocardiogram (ECG) and classic symptoms suggesting STEMI should be evaluated only with transthoracic echocardiography (TTE)
    HF from COVID-19 usually occurs in late pregnancy or within a few months postpartum, whereas peripartum cardiomyopathy (PPCM) may occur throughout pregnancy